NEW YORK, Sept 17 (Reuters) - New York state filed civil charges on Thursday accusing Johnson & Johnson JNJ.N of insurance fraud for downplaying the risks of opioid painkillers, including to elderly patients.
Governor Andrew Cuomo said the charges by New York's Department of Financial Services in that regulator's opioid industry probe follow charges against Teva Pharmaceutical Industries Ltd TEVA.TA, Allergan Plc, Endo International Plc ENDP.O and Mallinckrodt Plc MNK.N.
(Reporting by Jonathan Stempel in New York)
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
Latest Markets Videos
- US STOCKS-Wall St plunges as Snap's bleak forecast sparks selloff
- US STOCKS-Wall Street surges on upbeat retail guidance, easing Fed fears
- All Fed officials backed May rate hike, 'most' saw half-point rises in June and July, minutes show
- Fed could cut rates in 2023, 2024 once inflation under control -Bullard